These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25036423)

  • 21. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prenatal methadone on reinstated behavioral sensitization induced by methamphetamine in adolescent rats.
    Wong CS; Lee YJ; Chiang YC; Fan LW; Ho IK; Tien LT
    Behav Brain Res; 2014 Jan; 258():160-5. PubMed ID: 24157336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
    Oshibuchi H; Inada K; Sugawara H; Ishigooka J
    Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the effects of nicotine and methamphetamine on extracellular dopamine in the nucleus accumbens of behaviorally sensitized rats].
    Miyata H; Ando K; Yanagita T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Apr; 16(2):41-7. PubMed ID: 8905789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
    Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
    Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity.
    Rowley HL; Kulkarni R; Gosden J; Brammer R; Hackett D; Heal DJ
    Neuropharmacology; 2012 Nov; 63(6):1064-74. PubMed ID: 22796358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Simultaneous administration of ethanol emphasizes the effect of methamphetamine on central nervous system in rat with high alcohol preference].
    Yamauchi J; Marukawa S; Hishida S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Feb; 35(1):28-47. PubMed ID: 10737001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats.
    Izawa J; Yamanashi K; Asakura T; Misu Y; Goshima Y
    Eur J Pharmacol; 2006 Nov; 549(1-3):84-90. PubMed ID: 16979160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
    Northrop NA; Yamamoto BK
    Neuropharmacology; 2013 Sep; 72():96-105. PubMed ID: 23643743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
    Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment.
    Reid MS; Ho LB; Tolliver BK; Wolkowitz OM; Berger SP
    Brain Res; 1998 Feb; 783(1):133-42. PubMed ID: 9479062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
    Yun J
    Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.